User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Mechanisms of toxic cardiomyopathy

Primary tabs

download
  • Open access
  • PDF
  • 129.65 K
Hantson, Philippe [UCL]

BACKGROUND: Dilated cardiomyopathy is a frequent disease responsible for 40-50% of cases of heart failure. Idiopathic cardiomyopathy is a primary disorder often related to familial/genetic predisposition. Before the diagnosis of idiopathic cardiomyopathy is made, clinicians must not only rule out viral and immune causes, but also toxic causes such as drugs, environmental agents, illicit substances and natural toxins. OBJECTIVE: The objective of this review is to present recent data on the mechanisms underlying toxic cardiomyopathy. METHODS: The US National Library of Medicine Pubmed database was searched from 1980 to December 2017 utilizing the combinations of the search terms "toxic cardiomyopathy", "drugs", "anticancer drugs", "azidothymidine", "rosiglitazone", "carbon monoxide", "alcohol", "illicit drugs", "cocaine", "metamfetamine", "metals", "venom". A total of 339 articles were screened and papers that dealt with the pathophysiology of toxic cardiomyopathy, either in animal models or in clinical practice were selected, with preference being given to more recently published papers, which left 92 articles. Anticancer drugs: The mechanisms of anthracycline-induced cardiotoxicity are primarily related to their mechanisms of action as anticancer drugs, mainly the inhibition of topoisomerase II β and DNA cleavage. Additional metabolic or oxidative stress factors may play a part, together with interference with iron metabolism. The more recent drugs, trastuzumab and imatinib, also influence stress pathways. Antiretroviral agents: Azidothymidine is cardiotoxic as a result of mitochondrial toxicity. In addition to energy depletion, azidothymidine also increases the production of mitochondrial reactive oxygen species (ROS). Antidiabetic drugs: The cardiotoxicity of thiazolidinedione antidiabetic drugs is still under investigation, though interference with mitochondrial respiration or oxidative stress is suspected. Cocaine: Among the multiple mechanisms involved in cocaine-related cardiotoxicity, excessive sympathetic stimulation with increased myocardial oxygen consumption is well documented in the acute form of left ventricular dysfunction. As for cocaine-related cardiomyopathy, the role of apoptosis and ROS is under investigation. Ethanol: The aetiology of ethanol-related cardiotoxicity is multifactorial, with individual susceptibility being important. It involves apoptosis, alterations of the excitation-contraction coupling in cardiac myocytes, structural and functional alterations of the mitochondria and sarcoplasmic reticulum, changes in cytosolic calcium flows, changes in calcium sensitivity of myofilaments, alterations of mitochondrial oxidation, deregulation of protein synthesis, decrease of contractile proteins and disproportion between the different types of myofibrils, changes in the regulation of myosin ATPase, up-regulation of the L-type calcium channels, increase of oxidative stress, and induction of ANP and p21 mRNA expression in ventricular myocardium. Metamfetamines: Catecholamine-mediated toxicity is the probable cause, with a possible role for genetic susceptibility. Carbon monoxide: In addition to hypoxic injury, carbon monoxide is also directly toxic to the mitochondria, with impairment of mitochondrial respiratory chain at the cytochrome c oxidase level, decrease of glutathione concentrations and of ATP production. There is no evidence for a delayed dilated cardiomyopathy in survivors of an acute exposure. Metals: Cobalt-related cardiomyopathy probably results from interference with energy production and contractile mechanisms, but additional factors (nutrition, hypothyroidism) are often required. Antimony may cause lethal oxidative stress and cell death mediated by elevation in intra-cellular calcium. Proposed mechanisms for mercury toxicity include glutathione depletion, production of ROS, and interruption in selenium-dependent endogenous enzymatic reactions. The existence of a lithium-induced cardiomyopathy is still debated. Scorpion venom: Catecholamine release is the probable cause of acute cardiomyopathy following scorpion envenomation. CONCLUSIONS: The mechanisms behind toxic cardiomyopathy are complex and multifactorial but include interference with myocardial cell bioenergetics and intracellular calcium handling, the generation of ROS, neurohormonal stress, and induction of apoptosis.

Document type Article de périodique (Journal article) – Synthèse de littérature
Access type Accès libre
Publication date 2019
Language Anglais
Journal information "Clinical toxicology" - Vol. 57, no.1, p. 1-9 (2019)
Peer reviewed yes
Publisher Informa Healthcare ((United Kingdom) London)
issn 1556-3650
e-issn 1556-9519
Publication status Publié
Affiliations UCL - SSS/IREC/MEDA - Pôle de médecine aiguë
UCL - (SLuc) Service de soins intensifs
Keywords Drugs ; Environmental agents ; Illicit substances ; Metals ; Natural toxins
Links
  1. Elliott P., Andersson B., Arbustini E., Bilinska Z., Cecchi F., Charron P., Dubourg O., Kuhl U., Maisch B., McKenna W. J., Monserrat L., Pankuweit S., Rapezzi C., Seferovic P., Tavazzi L., Keren A., Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases, 10.1093/eurheartj/ehm342
  2. Ghadri Jelena-Rima, Wittstein Ilan Shor, Prasad Abhiram, Sharkey Scott, Dote Keigo, Akashi Yoshihiro John, Cammann Victoria Lucia, Crea Filippo, Galiuto Leonarda, Desmet Walter, Yoshida Tetsuro, Manfredini Roberto, Eitel Ingo, Kosuge Masami, Nef Holger M, Deshmukh Abhishek, Lerman Amir, Bossone Eduardo, Citro Rodolfo, Ueyama Takashi, Corrado Domenico, Kurisu Satoshi, Ruschitzka Frank, Winchester David, Lyon Alexander R, Omerovic Elmir, Bax Jeroen J, Meimoun Patrick, Tarantini Guiseppe, Rihal Charanjit, Y.-Hassan Shams, Migliore Federico, Horowitz John D, Shimokawa Hiroaki, Lüscher Thomas Felix, Templin Christian, International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology, 10.1093/eurheartj/ehy076
  3. Pelliccia Francesco, Sinagra Gianfranco, Elliott Perry, Parodi Guido, Basso Cristina, Camici Paolo G., Takotsubo is not a cardiomyopathy, 10.1016/j.ijcard.2017.12.009
  4. Montastruc Guillaume, Favreliere Sylvie, Sommet Agnès, Pathak Atul, Lapeyre-Mestre Maryse, Perault-Pochat Marie-Christine, Montastruc Jean-Louis, , Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance Database, 10.1111/j.1365-2125.2009.03596.x
  5. Swain Sandra M., Whaley Fredrick S., Ewer Michael S., Congestive heart failure in patients treated with doxorubicin : A retrospective analysis of three trials, 10.1002/cncr.11407
  6. Deidda Martino, Madonna Rosalinda, Mango Ruggiero, Pagliaro Pasquale, Bassareo Pier P., Cugusi Lucia, Romano Silvio, Penco Maria, Romeo Francesco, Mercuro Giuseppe, Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection : , 10.2459/jcm.0000000000000373
  7. McGowan John V, Chung Robin, Maulik Angshuman, Piotrowska Izabela, Walker J Malcolm, Yellon Derek M, Anthracycline Chemotherapy and Cardiotoxicity, 10.1007/s10557-016-6711-0
  8. Mercurio Valentina, Pirozzi Flora, Lazzarini Edoardo, Marone Giancarlo, Rizzo Paola, Agnetti Giulio, Tocchetti Carlo G., Ghigo Alessandra, Ameri Pietro, Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs, 10.1016/j.cardfail.2016.04.008
  9. Varga Zoltán V, Ferdinandy Peter, Liaudet Lucas, Pacher Pál, Drug-induced mitochondrial dysfunction and cardiotoxicity, 10.1152/ajpheart.00554.2015
  10. Kankeu Cynthia, Clarke Kylie, Passante Egle, Huber Heinrich J., Doxorubicin-induced chronic dilated cardiomyopathy—the apoptosis hypothesis revisited, 10.1007/s00109-016-1494-0
  11. Bloom Michelle W., Hamo Carine E., Cardinale Daniela, Ky Bonnie, Nohria Anju, Baer Lea, Skopicki Hal, Lenihan Daniel J., Gheorghiade Mihai, Lyon Alexander R., Butler Javed, Cancer Therapy–Related Cardiac Dysfunction and Heart Failure : Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging, 10.1161/circheartfailure.115.002661
  12. Henriksen Peter A, Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention, 10.1136/heartjnl-2017-312103
  13. Wojnowski Leszek, Kulle Bettina, Schirmer Markus, Schlüter Gregor, Schmidt Albrecht, Rosenberger Albert, Vonhof Stefan, Bickeböller Heike, Toliat Mohammad Reza, Suk Eun-Kyung, Tzvetkov Mladen, Kruger Anke, Seifert Silvia, Kloess Marita, Hahn Heidi, Loeffler Markus, Nürnberg Peter, Pfreundschuh Michael, Trümper Lorenz, Brockmöller Jürgen, Hasenfuss Gerd, NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity, 10.1161/circulationaha.105.576850
  14. Slamon Dennis J., Leyland-Jones Brian, Shak Steven, Fuchs Hank, Paton Virginia, Bajamonde Alex, Fleming Thomas, Eiermann Wolfgang, Wolter Janet, Pegram Mark, Baselga Jose, Norton Larry, Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2, 10.1056/nejm200103153441101
  15. Baron Kaitlin B., Brown Jennifer R., Heiss Brian L., Marshall Joanne, Tait Nancy, Tkaczuk Katherine H.R., Gottlieb Stephen S., Trastuzumab-Induced Cardiomyopathy: Incidence and Associated Risk Factors in an Inner-City Population, 10.1016/j.cardfail.2014.05.012
  16. ElZarrad M. Khair, Mukhopadhyay Partha, Mohan Nishant, Hao Enkui, Dokmanovic Milos, Hirsch Dianne S., Shen Yi, Pacher Pal, Wu Wen Jin, Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice, 10.1371/journal.pone.0079543
  17. Rainbolt T. Kelly, Saunders Jaclyn M., Wiseman R. Luke, Stress-responsive regulation of mitochondria through the ER unfolded protein response, 10.1016/j.tem.2014.06.007
  18. Maharsy Wael, Aries Anne, Mansour Omar, Komati Hiba, Nemer Mona, Ageing is a risk factor in imatinib mesylate cardiotoxicity : Ageing is a risk factor in imatinib mesylate cardiotoxicity, 10.1002/ejhf.58
  19. Hasinoff B. B., Patel D., O'Hara K. A., Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib, 10.1124/mol.108.050104
  20. Kerkela Risto, Woulfe Kathleen C., Durand Jean-Bernard, Vagnozzi Ronald, Kramer David, Chu Tammy F., Beahm Cara, Chen Ming Hui, Force Thomas, Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase, 10.1111/j.1752-8062.2008.00090.x
  21. Gao RY, Mol Med Rep, 4, 151 (2011)
  22. Kohler James J, Cucoranu Ioan, Fields Earl, Green Elgin, He Stanley, Hoying Amy, Russ Rodney, Abuin Allison, Johnson David, Hosseini Seyed H, Raper C Michael, Lewis William, Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy, 10.1038/labinvest.2009.39
  23. Lee Yie Hou, Goh Wilson Wen Bin, Ng Choon Keow, Raida Manfred, Wong Limsoon, Lin Qingsong, Boelsterli Urs A., Chung Maxey C. M., Integrative Toxicoproteomics Implicates Impaired Mitochondrial Glutathione Import as an Off-Target Effect of Troglitazone, 10.1021/pr400219s
  24. Nadanaciva Sashi, Dykens James A., Bernal Autumn, Capaldi Roderick A., Will Yvonne, Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration, 10.1016/j.taap.2007.06.003
  25. Vinetti Marco, Haufroid Vincent, Capron Arnaud, Classen Jean-François, Marchandise Sebastien, Hantson Philippe, Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms, 10.3109/15563650.2011.626421
  26. Haufroid Vincent, Hantson Philippe, CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants, 10.3109/15563650.2015.1049355
  27. Frustaci Andrea, Russo Matteo A., Morgante Emanuela, Scopelliti Fernanda, Aquilano Katia, Ciriolo Maria R., Grande Claudia, Verardo Romina, Chimenti Cristina, Oxidative myocardial damage in human cocaine-related cardiomyopathy : Oxidative stress in cocaine cardiomyopathy, 10.1002/ejhf.231
  28. Havakuk Ofer, Rezkalla Shereif H., Kloner Robert A., The Cardiovascular Effects of Cocaine, 10.1016/j.jacc.2017.05.014
  29. Hale Sharon L., Alker Kevin J., Rezkalla Shereif, Figures Gerald, Kloner Robert A., Adverse effects of cocaine on cardiovascular dynamics, myocardial blood flow, and coronary artery diameter in an experimental model, 10.1016/0002-8703(89)90226-3
  30. Pitts William R., Vongpatanasin Wanpen, Cigarroa Joaquin E., Hillis L. David, Lange Richard A., Effects of the Intracoronary Infusion of Cocaine on Left Ventricular Systolic and Diastolic Function in Humans, 10.1161/01.cir.97.13.1270
  31. Perreault Cynthia L., Hague Nancy L., Ransil Bernard J., Morgan James P., The effects of cocaine on intracellular Ca2+ handling and myofilament Ca2+ responsiveness of ferret ventricular myocardium, 10.1111/j.1476-5381.1990.tb14140.x
  32. Arora Sandeep, Alfayoumi Fadi, Srinivasan Venkatraman, Transient Left Ventricular Apical Ballooning After Cocaine Use: Is Catecholamine Cardiotoxicity the Pathologic Link?, 10.4065/81.6.829
  33. Li G., Cocaine Induces Apoptosis in Fetal Rat Myocardial Cells through the p38 Mitogen-Activated Protein Kinase and Mitochondrial/Cytochrome c Pathways, 10.1124/jpet.104.073494
  34. Kovacic Peter, Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer, 10.1016/j.mehy.2004.06.028
  35. Isabelle Marc, Vergeade Aurélia, Moritz Fabienne, Dautréaux Brigitte, Henry Jean-Paul, Lallemand Françoise, Richard Vincent, Mulder Paul, Thuillez Christian, Monteil Christelle, NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction, 10.1016/j.yjmcc.2006.11.011
  36. Virmani Renu, Robinowitz Max, Smialek John E., Smyth Dennis F., Cardiovascular effects of cocaine: An autopsy study of 40 patients, 10.1016/0002-8703(88)90078-6
  37. Paratz Elizabeth D., Cunningham Neil J., MacIsaac Andrew I., The Cardiac Complications of Methamphetamines, 10.1016/j.hlc.2015.10.019
  38. Islam Mohammed Nasimul, Kuroki Hisanaga, Hongcheng Bai, Ogura Yoshiaki, Kawaguchi Naomasa, Onishi Shunzo, Wakasugi Choei, Cardiac lesions and their reversibility after long term administration of methamphetamine, 10.1016/0379-0738(95)01765-b
  39. Nishida Naoki, Ikeda Noriaki, Kudo Keiko, Esaki Rie, Sudden Unexpected Death of a Methamphetamine Abuser with Cardiopulmonary Abnormalities, 10.1258/rsmmsl.43.3.267
  40. Ito Hiroki, Yeo Khung-Keong, Wijetunga Mevan, Seto Todd B., Tay Kevin, Schatz Irwin J., A Comparison of Echocardiographic Findings in Young Adults With Cardiomyopathy: With and Without a History of Methamphetamine Abuse, 10.1002/clc.20367
  41. Sutter M. E., Gaedigk A, Albertson T. E., Southard J., Owen K. P., Mills L. D., Diercks D. B., Polymorphisms in CYP2D6 may predict methamphetamine related heart failure, 10.3109/15563650.2013.818684
  42. Steiner Jennifer L., Lang Charles H., Etiology of alcoholic cardiomyopathy: Mitochondria, oxidative stress and apoptosis, 10.1016/j.biocel.2017.06.009
  43. Laurent D, J Cardiol Clin Res, 2, 1022 (2014)
  44. Leibing E., Meyer T., Enzymes and signal pathways in the pathogenesis of alcoholic cardiomyopathy, 10.1007/s00059-016-4459-8
  45. Li Shi-Yan, Gilbert Sara A.B., Li Qun, Ren Jun, Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress, 10.1016/j.yjmcc.2009.03.017
  46. Hung CL, Alcohol Alcohol, 52, 638 (2017)
  47. Ma Heng, Yu Lu, Byra Emily A., Hu Nan, Kitagawa Kyoko, Nakayama Keiichi I., Kawamoto Toshihiro, Ren Jun, Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: Role of protein phosphatases, 10.1016/j.yjmcc.2010.03.017
  48. Husemoen LL, Alcohol Clin Exp Res, 32, 1984 (2008)
  49. Schröder Jörg, Hamada Sandra, Altiok Ertunc, Almalla Mohammad, Koutziampasi Chrysoula, Napp Andreas, Keszei András, Hein Marc, Becker Michael, Detection of Acute Changes in Left Ventricular Function by Myocardial Deformation Analysis after Excessive Alcohol Ingestion, 10.1016/j.echo.2016.12.009
  50. Guzzo-Merello Gonzalo, Alcoholic cardiomyopathy, 10.4330/wjc.v6.i8.771
  51. Mirijello Antonio, Tarli Claudia, Vassallo Gabriele Angelo, Sestito Luisa, Antonelli Mariangela, d'Angelo Cristina, Ferrulli Anna, De Cosmo Salvatore, Gasbarrini Antonio, Addolorato Giovanni, Alcoholic cardiomyopathy: What is known and what is not known, 10.1016/j.ejim.2017.06.014
  52. Ren Jun, Wold Loren E., Mechanisms of alcoholic heart disease, 10.1177/1753944708095137
  53. Piano Mariann R., Phillips Shane A., Alcoholic Cardiomyopathy: Pathophysiologic Insights, 10.1007/s12012-014-9252-4
  54. Jung Yoon-seok, Lee Ji-sook, Min Young-gi, Park Jin-sun, Jeon Woo-chan, Park Eun-jung, Shin Joon-han, Oh Sungho, Choi Sang-Cheon, Carbon Monoxide-Induced Cardiomyopathy, 10.1253/circj.cj-13-1282
  55. Cha Yong Sung, Kim Hyun, Hwang Sung Oh, Kim Jang Young, Kim Yun Kwon, Choi Eun Hee, Kim Oh Hyun, Kim Hyung Il, Cha Kyoung Chul, Lee Kang Hyun, Incidence and patterns of cardiomyopathy in carbon monoxide-poisoned patients with myocardial injury, 10.3109/15563650.2016.1162310
  56. KJELDSEN KNUD, THOMSEN HENRIK KLEM, ASTRUP POUL, Effects of Carbon Monoxide on Myocardium : Ultrastructural Changes in Rabbits After Moderate, Chronic Exposure, 10.1161/01.res.34.3.339
  57. Cha Yong Sung, Kim Hyun, Lee Yoonsuk, Kwon Woocheol, Son Jung-Woo, Youk Hyun, Kim Hyung Il, Kim Oh Hyun, Park Kyung Hye, Cha Kyoung-Chul, Lee Kang Hyun, Hwang Sung Oh, Evaluation of relationship between coronary artery status evaluated by coronary computed tomography angiography and development of cardiomyopathy in carbon monoxide poisoned patients with myocardial injury: a prospective observational study, 10.1080/15563650.2017.1337910
  58. Prockop Leon D., Chichkova Rossitza I., Carbon monoxide intoxication: An updated review, 10.1016/j.jns.2007.06.037
  59. Thom S. R., Carbon monoxide-mediated brain lipid peroxidation in the rat, 10.1152/jappl.1990.68.3.997
  60. Fitzgerald Robert S., Dehghani Gholam Abbas, Kiihl Samara, Autonomic control of the cardiovascular system in the cat during hypoxemia, 10.1016/j.autneu.2012.11.005
  61. Takahashi Kenkichi, Cardiac Disturbances due to CO Poisoning in Experimental Animals, 10.1620/tjem.74.224
  62. Cooper Chris E., Brown Guy C., The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance, 10.1007/s10863-008-9166-6
  63. Lippi Giuseppe, Rastelli Gianni, Meschi Tiziana, Borghi Loris, Cervellin Gianfranco, Pathophysiology, clinics, diagnosis and treatment of heart involvement in carbon monoxide poisoning, 10.1016/j.clinbiochem.2012.06.004
  64. CHEN K, Response of the isolated heart to carbon monoxide and nitrogen anoxia, 10.1016/0041-008x(85)90408-9
  65. Suner Selim, Jay Gregory, Carbon Monoxide Has Direct Toxicity on the Myocardium Distinct from Effects of Hypoxia in an Ex Vivo Rat Heart Model : CARBON MONOXIDE MYOCARDIAL TOXICITY, 10.1111/j.1553-2712.2007.00012.x
  66. Meyer Grégory, André Lucas, Kleindienst Adrien, Singh François, Tanguy Stéphane, Richard Sylvain, Obert Philippe, Boucher François, Jover Bernard, Cazorla Olivier, Reboul Cyril, Carbon monoxide increases inducible NOS expression that mediates CO-induced myocardial damage during ischemia-reperfusion, 10.1152/ajpheart.00702.2014
  67. Motterlini Roberto, Foresti Roberta, Biological signaling by carbon monoxide and carbon monoxide-releasing molecules, 10.1152/ajpcell.00360.2016
  68. Alvarez Marco, Malécot Claire O, Gannier François, Lignon Jacques M, Antimony-induced cardiomyopathy in guinea-pig and protection by L-carnitine : Antimony and L-carnitine induced cardioprotection, 10.1038/sj.bjp.0706030
  69. Tirmenstein M.A., Plews P.I., Walker C.V., Woolery M.D., Wey H.E., Toraason M.A., Antimony-Induced Oxidative Stress and Toxicity in Cultured Cardiac Myocytes, 10.1006/taap.1995.1006
  70. Grice H. C., Munro I. C., Wiberg G. S., Heggtveit H. A., The Pathology of Experimentally Induced Cobalt Cardiomyopathies. A Comparison with Beer Drinkers' Cardiomyopathy, 10.3109/15563656908990934
  71. Packer Milton, Cobalt Cardiomyopathy : A Critical Reappraisal in Light of a Recent Resurgence, 10.1161/circheartfailure.116.003604
  72. Bradberry S. M., Wilkinson J. M., Ferner R. E., Systemic toxicity related to metal hip prostheses, 10.3109/15563650.2014.944977
  73. Prentice Jennifer R., Clark Matthew J., Hoggard Nigel, Morton Allison C., Tooth Claire, Paley Martyn N., Stockley Ian, Hadjivassiliou Marios, Wilkinson J. Mark, Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation, 10.1371/journal.pone.0066186
  74. Harrow James A.C., Das Prasun K., Dhalla Naranjan S., Influence of some divalent cations on heart sarcolemmal bound enzymes and calcium binding, 10.1016/0006-2952(78)90334-9
  75. Kleinfeld M, Stein E, Action of divalent cations on membrane potentials and contractility in rat atrium, 10.1152/ajplegacy.1968.215.3.593
  76. Hervouet Eric, Pecina Petr, Demont Jocelyne, Vojtíšková Alena, Simonnet Hélène, Houštěk Josef, Godinot Catherine, Inhibition of cytochrome c oxidase subunit 4 precursor processing by the hypoxia mimic cobalt chloride, 10.1016/j.bbrc.2006.04.014
  77. Clyne N., Hofman-Bang C., Haga Y., Hatori N., Marklund S. L., Pehrsson S. K., Wibom R., Chronic cobalt exposure affects antioxidants and ATP production in rat myocardium, 10.1080/003655101753267964
  78. Lewis Christian P. L., Demedts Maurits, Nemery Benoit, Indices of Oxidative Stress in Hamster Lung Following Exposure to Cobalt(II) Ions:In VivoandIn VitroStudies, 10.1165/ajrcmb/5.2.163
  79. Hatori Nobuo, Pehrsson Kenneth, Clyne Naomi, Hansson Göran, Hofman-Bang Claes, Marklund Stefan L., Rydén Lars, Sjöqvist Per-Ove, Svensso Lennart, Acute cobalt exposure and oxygen radical scavengers in the rat myocardium, 10.1016/0925-4439(93)90029-z
  80. Singer Irwin, Rotenberg Donald, Mechanisms of Lithium Action, 10.1056/nejm197308022890508
  81. ABDEL-ZAHER AHMED O., ABDEL-RAHMAN MAHMOUD M., LITHIUM CHLORIDE-INDUCED CARDIOVASCULAR CHANGES IN RABBITS ARE MEDIATED BY ADENOSINE TRIPHOSPHATE-SENSITIVE POTASSIUM CHANNELS, 10.1006/phrs.1998.0445
  82. Serinken Mustafa, Karcioglu Ozgur, Korkmaz Ayhan, Rarely seen cardiotoxicity of lithium overdose: Complete heart block, 10.1016/j.ijcard.2007.08.058
  83. Asim Kalkan, Selman Yeniocak, Suleyman Yazici, Ozgur Karcioglu, Ozlem Bilir, Gokhan Ersunan, Heart Attack in the Course of Lithium Overdose, 10.5812/ircmj.21731
  84. Anantha Narayanan Mahesh, Mahfood Haddad Toufik, Bansal Ojas, Baskaran Janani, Azzouz Muhammad S., Akinapelli Abhilash, Esterbrooks Dennis J., Acute cardiomyopathy precipitated by lithium: is there a direct toxic effect on cardiac myocytes?, 10.1016/j.ajem.2015.03.023
  85. Kitami Makiko, Oizumi Hideki, Kish Stephen J., Furukawa Yoshiaki, Takotsubo Cardiomyopathy Associated With Lithium Intoxication in Bipolar Disorder : A Case Report, 10.1097/jcp.0b013e3182a95a27
  86. Aichhorn W., Huber R., Stuppaeck C., Whitworth A. B., Cardiomyopathy after long-term treatment with lithium – more than a coincidence?, 10.1177/0269881106059696
  87. Rosero Enríquez Ángela Sofía, Ballesteros Prados Alejandro, Petcu Alexandru S., Cardiomyopathy Secondary to Long-Term Treatment With Lithium : A Case Report and Literature Review, 10.1097/jcp.0000000000000848
  88. Perez Antonio L., Tang W. H. Wilson, Contribution of Environmental Toxins in the Pathogenesis of Idiopathic Cardiomyopathies, 10.1007/s11936-015-0381-2
  89. Frustaci Andrea, Magnavita Nicola, Chimenti Cristina, Caldarulo Marina, Sabbioni Enrico, Pietra Romano, Cellini Carlo, Possati Gian Federico, Maseri Attilio, Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction, 10.1016/s0735-1097(99)00062-5
  90. Cupo Palmira, Clinical update on scorpion envenoming, 10.1590/0037-8682-0237-2015
  91. Abroug Fekri, Souheil Elatrous, Ouanes Islem, Dachraoui Fahmi, Fekih-Hassen Mohamed, Ouanes Besbes Lamia, Scorpion-related cardiomyopathy: Clinical characteristics, pathophysiology, and treatment, 10.3109/15563650.2015.1030676
  92. Nouira Semir, Elatrous Souheil, Besbes Lamia, Boukef Riadh, Devaux Christiane, Aubrey Nicolas, Elayeb Mohamed, Abroug Fekri, Neurohormonal activation in severe scorpion envenomation: correlation with hemodynamics and circulating toxin, 10.1016/j.taap.2005.01.017
  93. Ouanes-Besbes Lamia, El Atrous Souhail, Nouira Semir, Aubrey Nicolas, Carayon Alain, El Ayeb Mohamed, Abroug Fekri, Direct vs. mediated effects of scorpion venom: an experimental study of the effects of a second challenge with scorpion venom, 10.1007/s00134-005-2555-y
  94. Padilla Alejandro, Govezensky Tzipe, Possani Lourival D, Larralde Carlos, Experimental envenoming of mice with venom from the scorpion Centruroides limpidus limpidus: differences in mortality and symptoms with and without antibody therapy relating to differences in age, sex and strain of mouse, 10.1016/s0041-0101(03)00036-9
  95. Quintero-Hernández V., Jiménez-Vargas J.M., Gurrola G.B., Valdivia H.H., Possani L.D., Scorpion venom components that affect ion-channels function, 10.1016/j.toxicon.2013.07.012
  96. Abroug Fekri, Ouanes Islem, Maatouk Mezri, Golli Mondher, Ouanes-Besbes Lamia, Inverted Takotsubo syndrome in Androctonus australis scorpion envenomation, 10.1080/15563650.2017.1377221
  97. Madias John E., Scorpion envenomation cardiomyopathy: a promising model for takotsubo syndrome, 10.3109/15563650.2015.1052500
  98. Madias John E., Voltage attenuation of the electrocardiogram QRS complexes in a patient with “scorpion envenomation”–induced Takotsubo syndrome, 10.1016/j.ajem.2015.02.040
  99. Miranda Carlos Henrique, Braggion-Santos Maria Fernanda, Schmidt André, Filho Antônio Pazin, Cupo Palmira, Evolution of the electrocardiogram QRS complexes voltage in scorpion envenomation–induced Takotsubo syndrome, 10.1016/j.ajem.2015.02.039
  100. Miranda Carlos H., Braggion-Santos Maria F., Schmidt André, Pazin-Filho Antônio, Cupo Palmira, The first description of cardiac magnetic resonance findings in a severe scorpion envenomation, 10.1016/j.ajem.2014.12.044
Bibliographic reference Hantson, Philippe. Mechanisms of toxic cardiomyopathy. In: Clinical toxicology, Vol. 57, no.1, p. 1-9 (2019)
Permanent URL http://hdl.handle.net/2078.1/218312